Literature DB >> 19784620

[From GRIP to multimodal pain therapy. A concept asserts itself].

J Hildebrandt1, M Pfingsten.   

Abstract

Low back pain is still a big medical and social problem. During the last few decades a change of paradigm in treating non-specific low back pain has happened: physical activity and exercise therapy are now recommended as the first-line treatment in all relevant national and international guidelines. In chronic cases only biopsychosocial treatment concepts are successful, which have been introduced in Germany in 1990 in the form of the GRIP (Göttingen intensive low back program) for the first time. Meanwhile, this treatment has now been recommended by all evidence-based guidelines but we are still in the beginning of a full coverage care in Germany.

Entities:  

Mesh:

Year:  2009        PMID: 19784620     DOI: 10.1007/s00132-009-1479-6

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  17 in total

1.  Active therapy for chronic low back pain: part 3. Factors influencing self-rated disability and its change following therapy.

Authors:  A F Mannion; A Junge; S Taimela; M Müntener; K Lorenzo; J Dvorak
Journal:  Spine (Phila Pa 1976)       Date:  2001-04-15       Impact factor: 3.468

Review 2.  Is low back pain part of a general health pattern or is it a separate and distinctive entity? A critical literature review of comorbidity with low back pain.

Authors:  Lise Hestbaek; Charlotte Leboeuf-Yde; Claus Manniche
Journal:  J Manipulative Physiol Ther       Date:  2003-05       Impact factor: 1.437

Review 3.  What can the history and physical examination tell us about low back pain?

Authors:  R A Deyo; J Rainville; D L Kent
Journal:  JAMA       Date:  1992-08-12       Impact factor: 56.272

4.  Comorbid subjective health complaints in low back pain.

Authors:  Eli Molde Hagen; Erling Svensen; Hege R Eriksen; Camilla M Ihlebaek; Holger Ursin
Journal:  Spine (Phila Pa 1976)       Date:  2006-06-01       Impact factor: 3.468

5.  Opioid therapy for nonspecific low back pain and the outcome of chronic work loss.

Authors:  Ernest Volinn; Jamison D Fargo; Perry G Fine
Journal:  Pain       Date:  2009-01-31       Impact factor: 6.961

6.  Fear of movement/(re)injury in chronic low back pain and its relation to behavioral performance.

Authors:  Johan W S Vlaeyen; Ank M J Kole-Snijders; Ruben G B Boeren; H van Eek
Journal:  Pain       Date:  1995-09       Impact factor: 6.961

Review 7.  Multidisciplinary rehabilitation for chronic low back pain: systematic review.

Authors:  J Guzmán; R Esmail; K Karjalainen; A Malmivaara; E Irvin; C Bombardier
Journal:  BMJ       Date:  2001-06-23

8.  Back pain in the German adult population: prevalence, severity, and sociodemographic correlates in a multiregional survey.

Authors:  Carsten Oliver Schmidt; Heiner Raspe; Michael Pfingsten; Monika Hasenbring; Heinz Dieter Basler; Wolfgang Eich; Thomas Kohlmann
Journal:  Spine (Phila Pa 1976)       Date:  2007-08-15       Impact factor: 3.468

9.  A prospective two-year study of functional restoration in industrial low back injury. An objective assessment procedure.

Authors:  T G Mayer; R J Gatchel; H Mayer; N D Kishino; J Keeley; V Mooney
Journal:  JAMA       Date:  1987-10-02       Impact factor: 56.272

Review 10.  [Multimodal pain therapy: principles and indications].

Authors:  B Arnold; T Brinkschmidt; H-R Casser; I Gralow; D Irnich; K Klimczyk; G Müller; B Nagel; M Pfingsten; M Schiltenwolf; R Sittl; W Söllner
Journal:  Schmerz       Date:  2009-04       Impact factor: 1.107

View more
  11 in total

1.  [Effectiveness of intensive multimodal pain management programs].

Authors:  M Pfingsten; B Arnold; B Nagel; D Irnich
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

Review 2.  [Orthopedic aspects in interdisciplinary multimodal therapy of chronic back pain].

Authors:  L Weh; U Marnitz
Journal:  Schmerz       Date:  2011-06       Impact factor: 1.107

Review 3.  [Structure and process quality of multimodal pain therapy. Results of a survey of pain therapy clinics].

Authors:  B Nagel; M Pfingsten; T Brinkschmidt; H-R Casser; I Gralow; D Irnich; K Klimczyk; R Sabatowski; M Schiltenwolf; R Sittl; W Söllner; B Arnold
Journal:  Schmerz       Date:  2012-12       Impact factor: 1.107

4.  [Clinical studies on multimodal pain therapy : Standardized measurement of therapy outcomes with a core outcome set].

Authors:  S Deckert; R Sabatowski; J Schmitt; U Kaiser
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

5.  [Lifting capacity with low back pain : Discrepancy between self-rated and real lifting capacity in patients with back pain and pain-free controls].

Authors:  M Pfingsten; A Wendt; B Kröner-Herwig; S Lüder; J Hildebrandt; F Petzke
Journal:  Schmerz       Date:  2011-12       Impact factor: 1.107

Review 6.  [Multidisciplinary assessment for multimodal pain therapy. Indications and range of performance].

Authors:  H-R Casser; B Arnold; T Brinkschmidt; I Gralow; D Irnich; K Klimczyk; B Nagel; M Pfingsten; M Schiltenwolf; R Sittl; W Söllner
Journal:  Schmerz       Date:  2013-08       Impact factor: 1.107

7.  [Clinical pathway - conservative back pain treatment].

Authors:  S Füssel; J Matussek; D Boluki; C Lüring; J Grifka
Journal:  Orthopade       Date:  2010-08       Impact factor: 1.087

Review 8.  [Psychological approaches to pain in Germany. Review and outlook].

Authors:  M Pfingsten; H Flor; P Nilges
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

9.  [Acute inpatient multimodal pain therapy and rehabilitation: Framework conditions, tasks and differentiated patient allocation].

Authors:  B Arnold; H-R Casser; K Klimczyk; J Lutz; T Brinkschmidt; I Gralow; D Irnich; U Kaiser; B Nagel; M Schiltenwolf; M Pfingsten; R Sabatowski; W Söllner
Journal:  Schmerz       Date:  2015-12       Impact factor: 1.107

10.  Multidisciplinary pain management programs.

Authors:  Ulrike Kaiser; Bernhard Arnold; Michael Pfingsten; Bernd Nagel; Johannes Lutz; Rainer Sabatowski
Journal:  J Pain Res       Date:  2013-05-08       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.